Metallothioneins (MT) are low-molecular-weight, cysteine-rich, metal-binding proteins. MT genes are readily induced by various physiologic and toxicologic stimuli. Because the cysteines in MT are absolutely conserved across species, it was suspected that the cysteines are necessary for function and MT is essential for life. In attempts to determine the function(s) of MT, studies have been performed using four different experimental paradigms: (a) animals injected with chemicals known to induce MT; (b) cells adapted to survive and grow in high concentrations of MT-inducing toxicants; (c) cells transfected with the MT gene; and (d ) MTtransgenic and MT-null mice. Most often, results from studies using the first three approaches have indicated multiple functions of MT in cell biology: MT (a) is a "storehouse" for zinc, (b) is a free-radical scavenger, and (c) protects against cadmium (Cd) toxicity. However, studies using MT-transgenic and null mice have not strongly supported the first two proposed functions but strongly support its function in protecting against Cd toxicity. Repeated administration of Cd to MT-null mice results in nephrotoxicity at one tenth the dose that produces nephrotoxicity in control mice. Human studies indicate that 7% of the general population have renal dysfunction from Cd exposure. Therefore, if humans did not have MT, "normal" Cd exposure would be nephrotoxic to humans. Thus, it appears that during evolution, the ability of MT to protect against Cd toxicity might have taken a more pivotal role in the maintenance of life processes, as
INTRODUCTION
The discovery of a cadmium (Cd)-binding, cysteine-rich protein from horse kidney by Margoshes & Vallee (1) was the seminal finding that marked the birth of a field of research focused on the study of a low-molecular-weight polypeptide superfamily, the metallothioneins (MTs). MTs are low-molecularweight (6-7 kDa), nonenzymatic proteins ubiquitous in the animal kingdom (2, 3) . MT has an unusual amino acid composition: It does not contain aromatic amino acids, and most important, one third of its residues are cysteines.
Although MT was discovered over 40 years ago, its physiological functions are still unclear. Studies aimed at determining physiological function(s) of MTs have made use of four different model systems: (a) animals injected with chemicals known to induce MT; (b) cells adapted to survive and grow in high concentrations of toxicants; (c) cells transfected with the MT gene; and (d ) MT-transgenic and -null animals. Among these, the use of MT-transgenic and MT-null animals has provided the most persuasive evidence for the importance of MT in detoxification and protection against Cd and other heavy metals. Here, we emphasize the recent advances in understanding of the regulation and functional significance of MT.
STRUCTURE AND OCCURRENCE OF METALLOTHIONEIN
MTs have been found throughout the animal kingdom, in higher plants, in eukaryotic microorganisms, and in many prokaryotes (3, 4) . Based on their structural similarities, MTs have been divided into three classes: class I, II, and III. Class I MTs, which include mammalian MTs and any polypeptide from other phyla with related primary structure, are the focus of this review.
The amino acid sequences of MTs from many mammalian sources reveal that all contain approximately 61 amino acids of remarkably similar composition. More important, all contain 20 cysteine residues that remain invariant along the amino acid sequence. All cysteines are known to participate in the coordination of 7 mol of Cd or zinc (Zn) per mol of MT (5) . Coordination of these cysteine residues results in a high binding affinity for Zn (10 −18 ) and Cd (10 −22 ) (5) . Detailed structural properties of the individual mammalian MT metal coordinating sites have been obtained from 113 Cd-nuclear magnetic resonance (6) (7) (8) . The seven atoms of bound Cd are arranged in two separate polynuclear metal clusters, one containing three and the other four metal ions ( Figure 1 ). This satisfies the metal 7 (Cys) 20 stoichiometry for MT (9) . The three-metal cluster forms a cyclohexane-like six-membered ring requiring 9 cysteine thiolate ligands, whereas the four-metal cluster forms a bicyclo [3:1:3] structure, requiring 11 cysteine thiolate ligands. The four-metal cluster comprises residues 31-61 (COOH terminus). The binding of metals to each cluster is ordered (10), with initial binding to the four-metal cluster. After these sites are saturated, binding occurs at the three-metal cluster. Binding in each cluster is cooperative. Release of metals is also cooperative, with metal leaving the three-metal cluster first. Therefore, the three-metal cluster is more labile in the sense that it readily gives up bound Cd ions, whereas Cd is bound more tightly to the four-metal cluster.
A comparison of the primary structure of known mammalian MTs also reveals that most of the amino acid substitutions among species are conservative. The majority of nonconserved amino acids are located in the amino terminal half of MT, which may indicate that there are fewer evolutionary constraints on this region of the polypeptide chain (11). Also, from amino acid sequence comparisons, it has been suggested that class I MTs are slowly evolving at a rate intermediate to that of cytochrome c and hemoglobin (12). It is somewhat predictable from the high degree of conservation observed in the primary and secondary structure of mammalian MTs that the coding regions of MT genes are also strongly homologous, whereas the noncoding sequences are more divergent (2) .
Taken together, these facts about MT structure probably can be distilled into one simple principle: MT is functionally a very important protein and its structural conservation is dictated by its functional requirement. In addition to the need for positional constancy of the cysteines, the importance of the overall structural conservation of MT can be further demonstrated by the finding that simply changing the length of the interdomain hinge leads to a decline in its metal-binding ability. Thus, it cannot be overemphasized that the structure of mammalian MTs is the product of a functionally driven, evolutionarily selected process.
REGULATION OF MT GENE EXPRESSION
The current understanding of MT gene structure and regulation initially stemmed from studies on mouse and human MT genes. Although the mouse MT multigene family consists of four known members (MT-I through -IV) that are located on chromosome 8, human MTs are encoded by a multigene family of at least 15 members located on chromosome 16. They include one MT-II, MT-III, and MT-IV gene each and at least 13 MT-I genes (13-15). Although mouse MT-I and MT-II genes are coordinately regulated, MT-III is expressed in adult brain, and MT-IV in differentiating stratified squamous epithelium (14). However, all four isoforms are expressed in placenta (16). In humans, the MT-II isoform gene (MT-IIA) is the most highly expressed gene, accounting for almost 50% of total MT expression (17).
MT gene expression is controlled primarily at the level of transcription (18). In cells selected for resistence to Cd, enhanced expression of MT protein can also be achieved through MT gene amplification (19). The 5 end of MT-I and MT-II genes contain a TATA box (core promoter element) and numerous cis-acting response elements (promoter proximal elements). These cis-acting response elements include the metal responsive elements (MREs), glucocorticoid responsive elements, and antioxidant response elements (18-22). In addition to the metal and glucocorticoid responsive elements, human MT gene promoters contain a number of other response elements, including the following: basal level enhancer elements, GC-box, interferon responsive elements, TPA responsive elements, and AP2 binding sites (2, 15, (23) (24) (25) . Whereas MT promoter cis-acting elements may be unique to one gene or species, the single common motif from invertebrates to vertebrates is the MREs, which are always present in multiple copies in the MT-gene promoter (15).
Some of the response elements in the MT promoter are binding sites for putative transcription factors. For example, TPA responsive elements are recognized by AP1 and AP2, and the GC-box is the binding site for Sp1 transcription factor (15, 24, 25). However, studies aimed at identifying specific transcription factors have mainly focused on identifying the metal transcription factors that mediate MT gene expression by metals.
Several groups have reported proteins that bind to the metal-responsive DNA elements in mouse MTs (26). The candidate MRE-binding protein, termed MTF-1 for metal transcription factor-I (27), was subsequently cloned and found to be a Zn-finger (Cys 2 His 2 ) transcription factor (26, 28). Targeted disruption of both copies of MTF-1 allele in mouse embryonic stem cells resulted in silencing of constitutive as well as metal-mediated expression of MT-I and MT-II genes (26). Using a different approach, Palmiter (29) also demonstrated that MTF-1 is indispensable for basal and metal-mediated MT-gene expression. Thus, MTF-1 appears to be the only transcription factor that mediates metal responsiveness of the MT genes (29). However, MTF-1 itself appears to be under the control of a Zn-sensitive inhibitor. Thus, the current model for MT gene regulation by metals depicts that in the absence of Zn, MTF-1 is complexed with an inhibitor, termed MTI (metallothionein transcription inhibitor). In the presence of Zn, MTI dissociates from MTF-1, which allows it to interact with the MREs in the MT promoter to activate transcription. The newly synthesized MT binds Zn and the MTF-1/MTI complex reforms (29).
An attempt to generate MTF-1-null mutant mice resulted in embryos that died on day 14 of gestation (30). However, in the embryos, an absense of MTF-1 abolished the transcription of MT-I and MT-II genes and reduced the transcription of γ -glutamylcysteine synthetase, a key enzyme in glutathione synthesis. MTF-1-null embryos showed increased susceptibility to Cd and hydrogen peroxide and had liver degeneration. Thus, although MT is not essential for life, the metal transcription factor is.
REGULATION OF MT PROTEIN DEGRADATION
Degradation of MT protein is also an important aspect of MT regulation (31). There are tremendous differences in the half-lives of MT synthesized as a result of chemical induction of the MT gene. For example, the half-life of Zn-MT is approximately 18-20 h, whereas that of Cd-MT is about 3 days (32). Studies from our laboratory (33) showed that the half-life for constitutive MT in adult rats is about 4 h, whereas in neonates it is 49 h. MT induced by ethanol, ZnCl 2 or CdCl 2 also has widely different half-lives, approximately 9, 25, and 60 h, respectively (33), indicating that the degradation of MT is dependent on the age of the animals and the metal bound to MT.
Using cultured hepatocytes, Chen & Failla (34) showed that the degradation of MT is primarily regulated by cellular Zn content, and it occurs in both lysosomal and non-lysosomal compartments. The importance of cathepsin B in lysosomal fraction was demonstrated when cathepsin B-specific inhibitors were found to suppress apo-MT degradation by 80% (35) . This was further confirmed using purified cathepsin B (36) . It was also shown that MT is degraded rapidly when there are fewer than five atoms of metal associated with each molecule of MT (35, 36) . Concurrent titration studies indicated that at lysosomal pH, most of the Zn is released from MT whereas most of the Cd is not (36) . This could be the reason Cd MT has a higher half-life in vivo than does Zn MT. Steinbach & Wolterbeek (37) demonstrated that an intracellular MT pool exists in at least two forms, cytosolic apo-MT and lysosomal metal-bound MT, each being depleted and replenished at different rates. Subsequent studies showed that cytosolic apo-MT can be degraded by the cytosolic 26S proteasome complex (38) . The evidence that the intracellular MT pool can exist in independent, compartmentalized pools has important implications for the intracellular functions of MT.
During fetal development, tissue MT-I and MT-II concentrations change dramatically. Both MT-I and MT-II are detected in rat fetal liver by day 18 of gestation, reaching maximum hepatic concentrations at birth (39) . MT concentrations in liver of newborn rats are 20-fold higher than in adult rats. This high level of hepatic MT is maintained during the first 2 weeks postpartum. Thereafter, the hepatic concentration of MT decreases, with adult expression levels exhibited by 35 days of age (39) (40) (41) . One explanation for a consistently high level of MT during development is that MT is localized in the nucleus during development, and thus it is not available to the intracellular degradation machinery (31). Both MT-I and MT-II isoforms are coordinately regulated during development. MT levels in kidney, spleen, heart, lung, pancreas, and stomach are three-to ten-fold higher in 1-day-old rats than in adult rats and fall steadily to adult values over a 3-4 week period. In contrast, neonatal brain has lower (∼50%) MT concentrations and increases to adult level by day 21 (42) .
PROPOSED FUNCTIONS OF METALLOTHIONEIN

Role of Metallothionein in Essential Metal Homeostasis
ZINC Zn is a physiologically important metal and the most abundant metal bound to constitutive MT. Zn provides essential structural and catalytic functions to a wide variety of proteins. More than 300 different enzymes depend on Zn for proper protein folding and biological function. Zn is also crucial in the regulation of gene expression because numerous transcription factors have "zinc finger motifs" that are maintained by Zn.
Apo-MT (metallothionein with no metals bound) is a Zn acceptor because of the abundance of free sulfhydryl groups and their high affinity for Zn. However, the sulfhydryl groups are highly reactive, and Zn, although bound with high affinity, can undergo exchange reactions, which allows Zn to be transferred from MT to other proteins (43) (44) (45) (46) . The affinity of sulfhydryl groups for Zn can also make MT an efficient metal ion scavenger. This implies a possible regulatory role of MT in the activation or inactivation of various molecular effectors. Such a possibility was demonstrated by showing that apo-MT can chelate Zn out of the transcription factor IIIA (TFIIIA), a process that inactivates TFIIIA (47) . Therefore, it is tempting to speculate that MT might be essential for Zn homeostasis by regulating Zn absorption, or as a donor of Zn to various enzymes and transcription factors during development or protein synthesis.
The role of MT in intestinal Zn absorption was recently reevaluated using both MT-transgenic and MT-null mouse models (48) . At 2 h after a single oral dose of Zn, serum Zn concentrations were twofold higher in MT-null mice, while in MT-transgenic mice, serum Zn concentrations were only one-third that of controls, which suggests that MT reduces Zn absorption. Intestinal Zn was higher in MT-null mice but was unchanged in MT-transgenic mice, which suggests that MT does not reduce Zn absorption simply by sequestration of Zn in the mucosa (48) .
MT has been suggested to provide a biologically important pool of Zn during periods of extreme Zn deficiency, as the teratogenic effects observed in fetuses of dams placed on a Zn-deficient diet was lower in MT-I transgenic mice than in control mice (49) . Hepatic concentrations of Zn were 60% less in newborn MT-null mice than in control mice, and kidney development in the MT-null pups was retarded when they were fed a Zn-deficient diet (50) . However, these renal abnormalities resolved with time and did not impair kidney function (51) . When adult MT-null mice were challenged with a toxic dose of Zn, they had a greater incidence of pancreatic acinar cell degeneration compared with controls (50) . During endotoxemia, MT-null mice were also less responsive than control mice to hepatic Zn accumulation and to reduction in plasma Zn levels (52, 53) .
Thus, MT may aid in maintaining Zn homeostasis and protecting against excess Zn-induced toxicity. However, MT-null animals appear "normal," and thus MT does not appear to play the most crucial role in enabling Zn to perform its important roles in growth and development. However, it should be emphasized that the apparent "normal" appearance of MT-null mice could be due to the presence of back-up systems and thus does not necessarily argue against MT having a physiological role in Zn homeostasis.
COPPER Copper (Cu) is an essential metal for structural and catalytic properties of many enzymes, such as Cu/Zn superoxide dismutase, cytochrome c oxidase, and copper-responsive transcription factors. However, excess Cu can be toxic, particularly when associated with a deficit in Cu excretion (54) . There are two diseases in humans caused by abnormal transport of Cu: Wilson's disease and Menkes' disease. Wilson's disease is a hypercupremic state, whereas Menkes' disease is a hypocupremic state. Wilson's disease is due to a defect of a P-type ATPase (ATP7B), which is located on autosome 13 in humans and autosome 16 in rats (55) . As a result of the mutation in the Cu-efflux transporter (56) , there is an inability to transport Cu across the bile canalicular membrane, and thus Cu accumulates in liver during aging. Menkes' disease gene is located on the X chromosome and is characterized by a mutation of a copper efflux ATPase (ATP7A) (57) . This results in decreased transport of Cu across the placenta to the fetus, as well as in decreased efflux of Cu from the intestine into the blood, thereby creating a copper-deficient state. Both copperefflux ATPases and MT are important mechanisms affecting copper toxicity (58) .
Analysis of Wilson's disease patients suggests that MT is the major Cubinding protein in their liver, and increased liver MT levels assist in the detoxication of the accumulated Cu (59, 60) . Thus, the beneficial effects produced by Zn administration to Wilson's patients could be due to induction of MT (61) . Indeed, MT-rich cells are resistant to Cu toxicity (62) (63) (64) (65) . It has been proposed that MT protects against Cu toxicity by sequestration of Cu from critical cellular targets (58, 61) .
Cu is a transition metal and can exist in three oxidation states: Cu, Cu + , and Cu 2+ . It appears that MT containing Zn and Cu functions as an antioxidant; however, when MT is saturated with Cu, it becomes a prooxidant and may cause oxidative liver damage (66) (67) (68) .
The role of MT in Menkes' disease has been studied by crossing MT-Iand -II-null mice with mice carrying the Mottled-Brindled allele (Mo-BrJ), a murine model for X-linked Menkes' disease (69) . It is believed that Mo-BrJ males die from Cu-deficiency because of an inability to transport Cu from the intestine into the circulation. Because MT avidly binds Cu, elimination of MT in the intestine might enhance passage of Cu into the circulation, resulting in prolonged survival. Contrary to expectation, on an MT −/− background, most offspring of Mo-BrJ mice die before gestational day 11. These results suggest that MT protects against Cu toxicity in the embryo (69) .
Because Cu is an essential metal that binds to MT, one might anticipate that MT would have an essential role in the normal biological activity of Cu in the body. However, because mice with a targeted deletion of MT appear to be "normal," the results suggest that MT is not essential for Cu homeostasis. However, it does appear that MT can protect against the toxicity of Cu under extreme conditions.
Role of Metallothionein in Protection Against Metal Toxicity
CADMIUM Cd is an environmental pollutant toxic to a number of tissues. Acute exposure to Cd produces hepatic, pulmonary, and testicular injury, whereas chronic exposure results in renal and bone injury and cancer, as well as toxicity to other organs (70) . Numerous studies have suggested that MT plays an important role in Cd disposition and detoxication.
The factors that influence Cd absorption, distribution, and elimination are not well understood, but it is known that Cd is poorly absorbed after oral ingestion (71) . The role of MT in Cd disposition has been examined in MT-transgenic mice. Using this model, MT does not inhibit intestinal Cd absorption, nor does it affect initial Cd distribution to various tissues (72, 73) . However, MT decreases Cd elimination through the bile (74) and is a major factor for tissue retention of Cd (73, 75) .
The correlation between Cd resistance in cultured cells and cellular MT levels is strong and has been extensively documented (64) . Pretreatment of animals with low doses of Cd (76, 77) , Zn (76), ethanol (78) , diethylmaleate (79), or triterpenoids (80), all of which are known to increase MT, protect against acute Cd-induced lethality and hepatotoxicity. Newborn animals have a high level of hepatic MT and are resistant to Cd-induced hepatotoxicity (81, 82) . Similarly, MT-I-transgenic mice, which have concentrations of hepatic MT ten-fold higher than that of control mice (83) , are resistant to Cd-induced lethality and hepatotoxicity (84) . In comparison, MT-null mice show increased susceptibility to Cd-induced lethality (85, 86) and liver injury (86, 87) . Furthermore, Zn pretreatment, which cannot increase hepatic MT in MT-null mice, failed to protect against Cd-induced hepatotoxicity in MT-null mice. These data support the hypothesis that Zn-induced tolerance to Cd is also due to induction of MT (76, 87) . Collectively, both constitutive cellular MT and induction of MT by chemicals are important for the detoxication of Cd. MT-mediated hepatoprotection is due to the high-affinity sequestration of Cd by MT in the cytosol, thus reducing the amount of Cd available to injure other critical organelles (Figure 2) (77, 84) . Figure 3 illustrates how Cd is thought to produce renal toxicity. Cd is initially taken up by the liver. In the liver, Cd can bind with glutathione (GSH) and be excreted into bile. More important, Cd can bind to MT and be stored. Some Cd bound to MT leaks into the plasma and then is taken up by the kidney. Circulating Cd-MT complex is a potent nephrotoxicant (88, 89) . In lysosomes of the kidney, Cd is released and can bind to preformed MT in the kidney. When a critical concentration of Cd is reached in the kidney, renal injury occurs. Therefore, whether MT is beneficial or detrimental for chronic Cd-induced nephrotoxicity has been debatable (70, 90, 91) . To critically evaluate the role of MT in long-term Cd toxicity, MT-null mice were exposed chronically to Cd for 10 weeks, after which kidney function and kidney morphology were examined (92) . In these studies, MT-null mice were found to have an increased sensitivity to Cd-induced renal injury (Figure 4) , indicating that chronic Cd-induced nephropathy is not necessarily mediated through Cd-MT, as the prevailing theory held. The increased susceptibility of MT-null mice is most likely due to their inability to synthesize MT in response to Cd exposure. This is in contrast to control mice, where in response to Cd exposure renal MT concentrations increased dramatically (Figure 4) . Thus, MT is indeed beneficial and protects the kidney from Cd toxicity, as it does in the liver (92) .
In addition to kidney, MT-null mice are more susceptible than control mice to chronic Cd-induced hepatotoxicity, which is characterized by hepatomegaly and apoptosis (93) . MT-null mice are also more susceptible to chronic Cd-induced bone loss after oral exposure, as determined by fecal calcium excretion (94) . Repeated injection of Cd in MT-null mice produced more pronounced bone mass loss, increased opacity beneath the metaphyseal plates, caused bone marrow hyperplasia, and resulted in poorly mineralized bone, as compared with control mice (95) . Chronic Cd-induced anemia, inflammation, thymus atrophy, splenomegaly, and elevated serum IL-1 and TNF-α levels are also more pronounced in MT-null mice (96) . In contrast to other tissues, MT does not protect against Cd-induced testicular toxicity (97, 98) .
Renal tubular damage is probably the most common adverse health effect related to Cd exposure in humans, both in the general population and in occupationally exposed individuals. In several areas of Japan, Cd pollution of soil is subsequently bioaccumulated into rice grown for human consumption. These Cd-exposure cohorts have a high incidence of renal injury. Likewise, Belgian, Chinese, and German populations have been identified as groups exposed to a sufficient amount of environmental Cd to manifest renal tubular damage (99) . Figure 5 summarizes the results of a number of studies with humans environmentally exposed to Cd (99) . Renal injury in these subjects is Also noted in Figure 5 are data on recent human exposure to Cd. As can be seen, present-day human exposure results in renal concentrations of Cd that are known to produce renal injury. It has been calculated that 7% of the general population has Cd-induced kidney damage (99) .
MERCURY Inorganic mercury (HgCl 2 ) is a relatively potent inducer of MT (100, 101). Hg can readily substitute for Zn in the seven-metal thiolate cluster (102) and binds to both MT-I and MT-II isoforms (65, 103) .
MT-rich cells are resistant to the toxicity of HgCl 2 (64, 65, 104) . Induction of MT in the kidney protects against HgCl 2 -mediated nephrotoxicity (105) . The protective effects of MT against HgCl 2 toxicity appear to be due to MT binding Hg in the cytosol (65, 106) . Mice deficient in MT-I/II are more susceptible than controls to HgCl 2 -induced renal injury (107) . Thus, MT can protect against the toxicity of HgCl 2 .
Metallothionein as a Trap for Reactive Oxygen Species
MT has a high (30%) content of cysteine residues. It is reasonable to expect that sulfhydryl-rich MT may function in a manner similar to GSH, wherein MT provides an intracellular nucleophilic "sink" to trap electrophiles, alkylating agents, and free radicals (108) (109) (110) . MT can serve as a sacrificial scavenger for hydroxyl radicals and superoxide anion in vitro (111, 112) and can assume the function of superoxide dismutase in yeast (113) . The multiple cysteine residues of MT can be oxidized during oxidative stress, and the subsequent release of Zn has been proposed to be important in protection against oxidative damage (114, 115) . However, oxidation of MT in vivo has been difficult to demonstrate, and there have been controversial reports on the role of MT during oxidative stress. (119) . MT has been shown to be more effective than GSH at protecting DNA from hydroxyl anion radical attack (120), or H 2 O 2 -induced deoxyribose cleavage (121) . Transfection of cells with the MT gene confers resistance to t-BHP-induced cytotoxicity and lipid peroxidation, as well as to nitric oxide-induced DNA damage (122) (123) (124) . Studies with MTnull cells, either from embryonic cells (125) or from adult hepatocytes (126) , have shown that the absence of MT yields cells that are at increased sensitivity to t-BHP-induced cytotoxicity and oxidative damage. A recent study using HL-60 cells demonstrated a direct reaction of H 2 O 2 with the sulfhydryl groups of Zn-MT, which spares GSH from oxidation and releases Zn (127) . The released Zn has been proposed to be involved in stabilization of cell membranes (112) . Thus, the role of MT in protecting against t-BHP-and H 2 O 2 -induced oxidative stress has been demonstrated in cell systems, but whether this occurs in vivo remains to be seen.
TERT-BUTYLHYDROPEROXIDE
PARAQUAT AND ADRIAMYCIN Paraquat and adriamycin produce oxidative stress via redox cycling, which generates superoxide anion radicals (128) . Both paraquat and adriamycin are effective inducers of MT (116, 129, 130) . In intact animals, Zn pretreatment, an effective but nonspecific method for MT induction, protects against the toxicity of both chemicals (131) (132) (133) . MT-null embryonic cells (125) and MT-null mice (134) are more sensitive to paraquat toxicity, implying a protective role for MT. However, the role of MT in adriamycin toxicity is controversial. MT-null embryonic cells are not sensitive to adriamycin toxicity (135) , and MT-transgenic mice, which have only a two-or threefold higher level of MT in the heart, are not protected against adriamycin toxicity (136) . In contrast, mice engineered to express MT in heart (10-to 150-fold) are protected from adriamycin cardiotoxicity (137) and ischemia-reperfusion heart injury (138) . Neonatal cardiomyocytes isolated from these heart-specific MT-transgenic mice are also resistant to adriamycin-induced cytotoxicity and oxidative stress (139) . Whether the discrepancy in the role of MT in adriamycin toxicity is due to varying levels of intracellular MT or to a combination of other factors needs further clarification. RADIATION Irradiation by γ -, x-, and ultraviolet rays produces reactive oxygen species by the radiolysis of water in living cells. Because of its hydroxyl radical scavenging ability in vitro (111), MT might be expected to provide protection against the toxic effects of radiation. Pretreatment of mice with Zn protects against X-radiation-induced lethality (140, 141) . However, transfection of cells with MT genes failed to confer radio-resistance (142, 143) . In intact animals, MT-transgenic mice were not protected from γ -radiation-induced lethality and hematotoxicity (144) . In agreement with these findings, MT-null mice do not have an increased sensitivity to radiation-induced damage to cellular DNA, protein, and lipids (145) . At very low doses of radiation (0. 1-1. 0 Gy), MT-null mice appear to be more sensitive to radiation-induced leukocyte reduction, but they suffered similar damage at doses higher than 3.0 Gy (146) . Furthermore, Zn treatment of MT-null mice protected against the lethal effects of radiation, indicating that Zn-induced protection was not mediated through the induction of MT (145) .
It is proposed that MT localized in the cytosol may function in metal detoxication and protection from oxidative stress, whereas MT localized in the nucleus may provide protection against DNA-damaging electrophiles (147) . Indeed, MT-null cells are more susceptible to Cd-, t-BHP-, and anti-cancer drug-induced apoptotic lesions (92, 148) , have enhanced spontaneous mutations (149) , and are sensitive to Cd-induced protooncogene (c-jun) and tumor suppressor gene (p53) expression (150) . Whether such a susceptibility is related to cytosolic versus nuclear MT localization requires further investigation.
CONCLUSIONS Although biochemical data indicate that MT can quench various reactive oxygen species and other electrophiles, current data from MT-null animals are less than convincing with regard to MT having a major role in protecting cells against reactive oxygen species. In addition, reactive oxygen species are thought to be important in aging, cancer, and neurodegenerative diseases, yet MT-null mice do not appear to suffer from premature aging, an increased incidence of cancer, or neurodegenerative disease. Thus, it does not appear likely that the conservation of MT resulted from evolutionary pressure to protect cells from reactive oxygen species or other electrophiles. In addition, if the main function of MT is to bind reactive chemical species, why would the location of the cysteine residues be conserved, and why would the sulfhydryl moieties not be freely available to bind electrophiles instead of being bound to metal?
Metallothionein-Mediated Protection Against the Toxicity of Other Chemicals
CISPLATIN cis-Diaminedichloroplatinum (cisplatin) is an effective anticancer drug containing the metal platinum. Binding of cisplatin to MT has been demonstrated (151) , but the role of MT in cisplatin resistance has been an issue of debate (110, 152) .
Some tumor cell lines with acquired resistance to cisplatin overexpress MT (153), whereas other cisplatin-resistant cell lines do not have increased MT levels (154) . Pretreatment of mice with MT-inducers, such as Zn and bismuth, protects against the lethal and nephrotoxic effects of cisplatin (155) . However, in other studies, induction of MT in rats failed to protect against the toxicity of cisplatin (156) . Transfection of cells with the hMT-IIA gene confers resistance to cisplatin toxicity in some cell lines (143, 157) but not in others (142, 158, 159) . Targeted deletion of the MT gene renders cells and animals more vulnerable to cisplatin toxicity (148, 160, 161) . In contrast, overexpression of MT in MT-transgenic mice does not confer resistance to cisplatin-induced nephrotoxicity (144) .
Overall, studies with cisplatin suggest that MT protection against cisplatin toxicity is equivocal at best. Therefore, it seems unlikely that MT plays a critical role in modulating cisplatin toxicity. (163) . Recent studies with MT-null mice suggest that a lack of MT also renders animals more susceptible to CCl 4 hepatotoxicity (146, 167) , providing further evidence of a role for MT as a cellular mechanism in decreasing CCl 4 toxicity. However, the ability of MT to scavenge trichloromethyl radicals in vivo could not be confirmed by the spin-trap chemical phenyl N-tert-butylnitrone (PBN) (168) . Thus, it has been suggested that the oxidation of MT by CCl 4 , with subsequent Zn release, rather than covalent binding, is responsible for protection (169) . ACETAMINOPHEN MT is induced following acetaminophen administration (170) , and induction of MT has been associated with protection against acetaminophen hepatotoxicity (171) (172) (173) . However, there is evidence neither for the binding of acetaminophen to MT nor for an altered subcellular distribution of acetaminophen following induction of MT by Zn (172), or by triterpenoids (173) . MT-I/II-null mice are more susceptible than control mice to acetaminophen hepatotoxicity (174, 175) . The increased susceptibility is not due to altered acetaminophen bioactivation, as P-450 enzymes, and acetaminophen metabolites appear to be unaltered in these MT-null animals. The cellular GSH content and covalent binding of acetaminophen to 44-and 58-kDa proteins are also similar in MT-null and control mice (174, 175) . The increased sensitivity to acetaminophen in MT-null mice has been suggested to be due to increased oxidative stress, as N-acetyl-benzoquinoimine, a reactive intermediate of acetaminophen biotransformation, produced more oxidative damage to MT-null than to control hepatocytes (175) .
STREPTOZICIN, ALLOXAN, AND CAERULEIN Pancreas has the highest basal concentration of MT (84, 176) . Pancreatic MT can be further increased by metals and chemicals that produce diabetes. Because of the high basal levels, the percentage increase in MT is not as pronounced as in liver and kidney. Induction of pancreatic MT by Zn has been associated with protection against streptozotocin-and caerulein-induced acute pancreatitis (177-179) but not protect against alloxan-induced injury to endocrine cells of the pancreas (180) . Both MT-transgenic and MT-null mice have been used to study the role of MT in chemical-induced pancreatic injury. MT-I-transgenic mice are more resistant, whereas MT-null mice are more sensitive to caerulein-induced pancreatitis than are corresponding control mice (181) . However, the differences are subtle. Treatment of MT-null mice with Zn protects against streptozocin-induced pancreatitis, which suggests that Zn, rather than MT, is more important in this protection (182) .
Metallothionein and Protection Against Neurodegenerative Disease
MT in brain has been proposed to play a role in Zn homeostasis and neurodegenerative diseases (183) (184) (185) (186) . Brain MT-III was discovered as a growth-inhibiting factor, inhibiting neuronal sprouting in culture (187) . MT-III was originally thought to be down-regulated in Alzheimer patients (187, 188) . However, further studies could not confirm the association of MT-III with Alzheimer's disease (189, 190) .
Transgenic mice that overexpress human MT-III have also been engineered (191) . They have a ninefold increase in MT-III in cerebral cortex, a three-to fivefold increase in hippocampus, thalamus, brain stem, and olfactory bulb, and a 1.4-fold increase in cerebellum. MT-III-null mice have also been made (192) . The concentration of Zn in several brain regions of the MT-III-null mice is lower than that of controls, but the pool of histochemically reactive Zn is not disturbed. No neuropathology or behavioral deficits were detected in 2-yearold MT-III-null mice, but they were more susceptible to kainic acid-induced seizures and brain injury.
Brain MT-I and II, but not MT-III, can be induced by Cd, Zn, endotoxin, kainic acid, and 6-hydroxydopamine (184, (193) (194) (195) . However, MT-I/II-null mice do not have an increased sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropridine (MPTP)-induced neurotoxicity, a model for Parkinson's disease (P Rojas & CD Klaassen, manuscript in preparation).
WHY WAS METALLOTHIONEIN EVOLUTIONARILY CONSERVED?
The long-held belief that the principal physiological functions of MT are Zn and Cu homeostasis as well as protection against oxidative stress (2, 3, 109) , although supported by earlier biochemical studies, has been challenged recently by studies using MT-null mice. These MT-null mice are "normal" but highly susceptible to Cd toxicity, indicating that MT is not essential for life.
Why is MT highly conserved through evolution? What would have been the selective disadvantage if MTs were lost during the course of evolution? It is well documented in the evolutionary literature that the more functionally constrained a structure, the slower its evolutionary rate (i.e. the functionally important parts of a gene or protein will evolve at a much slower rate than the functionally less-or nonimportant parts), particularly if the nonsynonymous substitutions are concerned. This trend can be explained by both natural selection and the neutral theory (196) (197) (198) . The differences in MT gene structure also conform to this rule, as the untranslated regions are a lot more divergent than are the coding regions. This further reinforces a question: Why is it necessary for MT structure, in particular the position of cysteines, to be so well conserved through evolution? What selective advantage does MT impart to the survival/perpetuation of the species that has MT? According to the Darwinian view of evolution, appearance of any character (variation) is a random event and is independent of the need. It is the selective advantage of that variation to the species that leads to its fixation in the population and to further adaptive changes during the course of evolution. Thus, MTs might have appeared as a small metal-binding ligand molecule early in the history of life, but it was obviously a characteristic offering selective advantage to life and thus was favored by natural selection. Although the driving force behind the further evolution of MT is subject to speculation, its metal-binding ability appears to have been a major determinant in its subsequent evolution. This is evidenced by the overall structural conservation of MT, particularly the positions of the cysteine residues, and the resulting slow evolutionary rate.
A snapshot of MT structure and function in prokaryotes and lower eukaryotes, mollusks, and mammals offers some clues to its structural and functional evolutionary trend. It appears that early in evolution, the main function of MT (the class II MTs) (2-4) was to preferentially bind to and be induced by physiologically important metals. For example, studies on the regulation of MT gene from the cyanobacteria Synechococcus (199, 200) indicate that as in mammals, various metal ions including Cd, Zn, and Cu increase the abundance of the transcript (200) . However, unlike mammalian MT, the most potent inducer of Synechococcus MT in vivo is Zn, followed by Cu and Cd. Similarly, the main functions of MT in the lower eukaryote yeast Saccharomyces is to detoxify Cu by maintaining low levels of the free ion (201) . In terrestrial gastropods, there are two distinct structural and functional types of MTs, one that preferentially binds Cu and one that binds Cd. Evidently, these two MT types serve two different functions (202) . The story of mammalian MT is best known and has been discussed in preceding sections. Thus, MT evolution has made it a perfect metal-binding molecule whose inducibility and metal-binding ability have undergone changes throughout the course of evolution from lower to higher forms. Events such as gene duplication and subsequent evolution of the duplicated genes following split from the ancestral one have led to the structural divergence of species-specific MT genes (2, 3) . Nevertheless, the metal-binding ability of MT protein remains unaltered.
If MT is so well conserved because it is an important protein, why are MT-null mice normal? An answer to this question leads us to think that MT may not have a critical role in normal Zn biology, or there exists a parallel/back-up system to compensate for the loss of MT. In contrast, the increased susceptibility of MT-null mice to Cd reinforces the protective role of MT against Cd toxicity. These explanations are actually in contrast to the long-held belief that the primary function of MT is in maintaining Zn and/or Cu homeostasis, and that protection from Cd toxicity is an adjunct function dictated merely by its structure.
Although the appearance and evolution of MT was probably not dictated by Cd, with the evolution of higher life forms, it appears, MT became more indispensible for protection against Cd and other heavy-metal toxicity than for performing the other suggested functions. It also appears that additional/alternative mechanisms to compensate for the loss of MT have evolved in mammals, but no such mechanisms have evolved to protect against Cd toxicity. That is why MT-null mice are normal but are highly susceptible to Cd toxicity. This thesis, however, does not negate other suggested functions of MT. MT in normal mice may still be among the first line of effector molecules modulating intermolecular Zn transfer, and it may form a significant line of defense against oxidative stress. But whereas these functions are not impaired in the absence of MT, there is no mechanism to protect the animals from Cd toxicity.
Although the physiological functions of MT are still elusive, and a number of functions have been attributed to it, they are all subject to debate. On the contrary, the only function of MT that has almost been unequivocally established (that has not been contradicted) is its role in protection against Cd toxicity. It has been calculated that 7% of the general population have Cdinduced kidney alterations due to chronic Cd exposure (99) . Incidents of chronic human Cd exposure in developed as well as developing countries are well documented. In each case, chronic Cd exposure manifested in renal proximal tubular cell damage (99) . So what would the significance be if humans did not have MT? If one would examine the human data from Figure 5 and impose renal dysfunction at one-tenth the amount known to produce renal dysfunction in humans (because Cd produces nephrotoxicity in MT-null mice at one-tenth the dose in control mice), there would be a major overlap in the incidence of Cd exposure and altered renal function. That is to say, a large percentage of the human population would be victims of Cd-induced nephropathy. Thus, MT also appears to be critical for human health for protection from Cd toxicity. 
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